(Q34312513)

1 August 2017

1 reference

title

Ramipril. An updated review of its therapeutic use in essential hypertension and heart failure (English)

1 reference

1 August 2017

1 reference

essential hypertension

1 reference

Frampton JE

1

1 reference

1 August 2017

Peters DH

series ordinal

2

1 reference

1 August 2017

publication date

1 March 1995

1 reference

1 August 2017

1 reference

1 August 2017

volume

49

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

440-466

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199549030-00008

1 August 2017

exact match

0 references

cites work

Differences in structure of angiotensin-converting enzyme inhibitors might predict differences in action

1 reference

12 December 2020

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

1 reference

12 December 2020

Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Comparison of response rates to the angiotensin-converting enzyme inhibitor ramipril in mild-to-moderate hypertension in a double-blind, parallel-group study and an open single-blind study

1 reference

12 December 2020

Antihypertensive efficacy, tolerance, and safety of ramipril in young vs. old patients: a retrospective study

1 reference

12 December 2020

Cough and ACE inhibitors

1 reference

12 December 2020

ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients

1 reference

12 December 2020

Ramipril and captopril in patients with heart failure: effects on hemodynamics and vasoconstrictor systems.

1 reference

12 December 2020

Assessment of the efficacy, tolerance, and safety of ramipril in diabetic patients with mild-to-moderate hypertension: a retrospective analysis

1 reference

12 December 2020

Clinical pharmacology of ramipril

1 reference

12 December 2020

The pharmacokinetic and pharmacodynamic interactions of ramipril with propranolol

1 reference

12 December 2020

[The nephroprotective effect of ramipril. Effect on blood pressure and metabolic control in insulin-treated patients with type-2 diabetes mellitus]

1 reference

12 December 2020

[Indications for ACE inhibitors in the postinfarct period]

1 reference

12 December 2020

Cough and ACE inhibitors

1 reference

12 December 2020

Lessons learned with ambulatory blood pressure monitoring: a focus on ramipril.

1 reference

12 December 2020

Effects of ACE inhibition supplementary to beta blockers and diuretics in early diabetic nephropathy

1 reference

12 December 2020

Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use.

1 reference

12 December 2020

Angiotensin converting enzyme binding sites in human heart and lung: comparison with rat tissues

1 reference

12 December 2020

The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment

1 reference

12 December 2020

Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs

1 reference

12 December 2020

The French multicentre study of ramipril in ambulatory patients with mild-to-moderate hypertension

1 reference

12 December 2020

Comparison of ramipril against atenolol in controlling mild-to-moderate hypertension

1 reference

12 December 2020

"Cardioprotection" by ACE-inhibitors in acute myocardial ischemia and infarction?

1 reference

12 December 2020

The pharmacokinetics of ramipril in a group of ten elderly patients with essential hypertension

1 reference

12 December 2020

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

12 December 2020

Hypertension: are beta-blockers and diuretics appropriate first-line therapies?

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors in angina and myocardial infarction. What role will they play in the 1990s?

1 reference

12 December 2020

Large prospective study of ramipril in patients with hypertension. CARE Investigators.

1 reference

12 December 2020

Preliminary experiences with HOE 498, a novel long-acting converting enzyme inhibitor, in hypertensive patients

1 reference

12 December 2020

Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders

1 reference

12 December 2020

Pharmacokinetics and effects on the renin-angiotensin system of ramipril in elderly patients

1 reference

12 December 2020

Study of the efficacy and safety of the combination ramipril 2.5 mg plus hydrochlorothiazide 12.5 mg in patients with mild-to-moderate hypertension. ATHES Study Group.

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension

1 reference

12 December 2020

Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors

1 reference

12 December 2020

Influence of ramipril on renal function in patients with chronic congestive heart failure.

1 reference

12 December 2020

1 reference

12 December 2020

Combined treatment of severe essential hypertension with the new angiotensin converting enzyme inhibitor ramipril

1 reference

12 December 2020

Modulation of sympathetic control by ACE inhibitors.

1 reference

12 December 2020

A comparison of the efficacy and safety of ramipril and digoxin added to maintenance diuretic treatment in patients with chronic heart failure

1 reference

12 December 2020

Effects of ramipril on the neurohormonal response to exercise in patients with mild or moderate congestive heart failure

1 reference

12 December 2020

Clinical pharmacokinetics of the newer ACE inhibitors. A review

1 reference

12 December 2020

Contribution of bradykinin to the cardiovascular effects of ramipril

1 reference

12 December 2020

Drug therapy of renovascular hypertension

1 reference

12 December 2020

Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Comparison of ramipril and enalapril in patients with essential hypertension.

1 reference

12 December 2020

Ambulatory 24-H Blood Pressure Monitoring in Essential Hypertensives Treated with the Angiotensin-Converting Enzyme Inhibitor Ramipril

1 reference

12 December 2020

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

12 December 2020

Combination of ramipril and hydrochlorothiazide in the treatment of mild to moderate hypertension: Part 1--A double-blind, comparative, multicenter study in nonresponders to ramipril monotherapy

1 reference

12 December 2020

Effect of bradykinin on arteries and veins in systemic and pulmonary circulation

1 reference

12 December 2020

Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Blood pressure response of nephrectomized subjects and patients with essential hypertension to ramipril: indirect evidence that inhibition of tissue angiotensin converting enzyme is important

1 reference

12 December 2020

Comparative pharmacokinetic and clinical profiles of angiotensin-converting enzyme inhibitors and calcium antagonists in systemic hypertension

1 reference

12 December 2020

Global and regional hemodynamic effects of ramipril in congestive heart failure

1 reference

12 December 2020

Ramipril vs captopril in mild to moderate hypertension

1 reference

12 December 2020

Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension

1 reference

12 December 2020

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

1 reference

12 December 2020

Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man

1 reference

12 December 2020

Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders

1 reference

12 December 2020

Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

Pharmacological treatment of hypertension

1 reference

12 December 2020

Recent advances in pharmacological management of hypertension in diabetic patients with nephropathy. Effects of antihypertensive drugs on kidney function and insulin sensitivity

1 reference

12 December 2020

Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group

1 reference

12 December 2020

Comparison of the antiatherogenic effects of isradipine and ramipril in cholesterol-fed rabbits: II. Effect on regression of atherosclerosis and restoration of endothelial function

1 reference

12 December 2020

Acute haemodynamic effects and pharmacokinetics of ramipril in patients with heart failure. A placebo controlled three-dose study.

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury: an overview.

1 reference

12 December 2020

Acute and chronic effects of ramipril and captopril in congestive heart failure

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV).

1 reference

12 December 2020

Ramipril and methyldopa compared in patients with mild to moderate hypertension

1 reference

12 December 2020

The effects of ACE inhibition on progression of atherosclerosis

1 reference

12 December 2020

Cardiovascular and renal effects of ramipril

1 reference

12 December 2020

Acute hemodynamic and hormonal effects of ramipril in chronic congestive heart failure and comparison with captopril

1 reference

12 December 2020

Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension

1 reference

12 December 2020

Short report: ramipril and hydrochlorothiazide combination therapy in hypertension: a clinical trial of factorial design. The East Germany Collaborative Trial Group.

1 reference

12 December 2020

Small doses of ramipril to reduce microalbuminuria in diabetic patients with incipient nephropathy independently of blood pressure changes

1 reference

12 December 2020

A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man

1 reference

12 December 2020

Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension

1 reference

12 December 2020

An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertension.

1 reference

12 December 2020

Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man

1 reference

12 December 2020

Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency.

1 reference

12 December 2020

Pharmacokinetics of ramipril in the elderly

1 reference

12 December 2020

A multi-centre comparative study between ramipril and enalapril in patients with mild to moderate essential hypertension

1 reference

12 December 2020

Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders

1 reference

12 December 2020

Multiple-dose pharmacokinetics of ramipril in patients with chronic congestive heart failure.

1 reference

12 December 2020

Cardioprotective potential of angiotensin converting enzyme inhibitors

1 reference

12 December 2020

The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension

1 reference

12 December 2020

Converting-enzyme inhibitors in the treatment of hypertension

1 reference

12 December 2020

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

1 reference

12 December 2020

Converting enzyme inhibitors in cardiovascular therapy: current status and future potential

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

24-hour blood pressure profiles in hypertensive patients administered ramipril or placebo once daily: Magnitude and duration of antihypertensive effects

1 reference

12 December 2020

Use of ACE Inhibitors in the Treatment of Cardiovascular Disease

1 reference

12 December 2020

Cough with angiotensin converting enzyme inhibitors: how much of a problem?

1 reference

12 December 2020

Regression of Increased Left Ventricular Mass by Antihypertensives

1 reference

12 December 2020

Therapeutic efficacy and tolerance of ramipril in hypertensive patients with renal failure.

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibition on human tissue renin

1 reference

12 December 2020

Amlodipine versus ramipril in the treatment of mild to moderate hypertension: evaluation by 24-hour ambulatory blood pressure monitoring

1 reference

12 December 2020

Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Preliminary results of biliary excretion of ramipril after T-drainage in cholecystectomy patients

1 reference

12 December 2020

The new trials: AIRE, ISIS-4, and GISSI-3. Is the dossier on ACE inhibitors and myocardial infarction now complete?

1 reference

12 December 2020

ACE inhibition, atherosclerosis and myocardial infarction--the AIRE Study in practice. Acute Infarction Ramipril Efficacy Study.

1 reference

12 December 2020

Double-blind, placebo-controlled study of ramipril in diabetics with mild to moderate hypertension

1 reference

12 December 2020

Comparison of the antiatherogenic effects of isradipine and ramipril in cholesterol-fed rabbits: I. Effect on progression of atherosclerosis and endothelial dysfunction

1 reference

12 December 2020

Antihypertensive efficacy, tolerance, and safety of long-term treatment with ramipril in patients with mild-to-moderate essential hypertension

1 reference

12 December 2020

Trough/peak ratios for antihypertensive agents. The issues in perspective

1 reference

12 December 2020

Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet

1 reference

12 December 2020

Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension

1 reference

12 December 2020

Monotherapy with the ACE-inhibitor ramipril or the calcium antagonist nitrendipine in essential hypertension

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibitors in left ventricular dysfunction: results of the studies of left ventricular dysfunction in the context of other similar trials.

1 reference

12 December 2020

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

12 December 2020

FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug Administration

1 reference

12 December 2020

Inhibition of ACE/kininase-II, acute myocardial infarction, and survival

1 reference

12 December 2020

Use of nuclear magnetic resonance imaging to show regression of hypertrophy with ramipril treatment

1 reference

12 December 2020

Usefulness of piretanide plus ramipril for systemic hypertension: a multicenter trial.

1 reference

12 December 2020

The effects of ramipril on glucose tolerance, insulin secretion, and insulin sensitivity in patients with hypertension

1 reference

12 December 2020

Tolerability of ramipril in a multicenter study of mild-to-moderate hypertension in general practice

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Trandolapril. How does it differ from other angiotensin converting enzyme inhibitors?

1 reference

12 December 2020

10.2165/00003495-199549030-00008

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1005833561

0 references

1 reference